Additionally, using the prime-boost, adjuvant, and viral vectors of M. tuberculosis antigens or BCG, it is possible to generate CD4+ and CD8+ lung Trms that improve protection against TB challenge [127]. The gene discussed is CD8A; the disease is tuberculosis.